XWELL Q1 revenue up 24% to $8.7M; operating loss narrows 62% to $2.4M

XWELL, Inc.

2024-Q1 EPS reported -$0.60 revenue$8,726,000

Revenue $8.7M vs $7.1M YoY; XpresSpa/Treat $4.4M, XpresTest $3.6M, Naples Wax $0.6M.
Operating loss improved 62% to $2.4M; net loss $2.5M vs $5.5M.
Cash $4.3M, marketable securities $14.8M; no long-term debt.
CDC TGS program expanded to Miami/Chicago; estimated funding increased to $36.7M.
Plans to open 3 new Naples Wax Centers in 2024 and XpresSpa at NYC Penn Station this summer.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.88

XWELL, Inc. reported financial results for the first quarter ended March 31, 2024.

Period: the first quarter ended March 31, 2024
Result: reported results

Exact text from the filing

On May 15, 2024, XWELL, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2024, and provided a corporate update.

View on SEC.gov

1047 earnings releases filed in the last 30 days. Browse all earnings releases →

XWELL, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-061978

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.